FERRLECIT

This brand name is authorized in United States. It is also authorized in Canada, Germany, Israel.

Active ingredients

The drug FERRLECIT contains one active pharmaceutical ingredient (API):

1	Sodium ferric gluconate complex in sucrose UNII CC9149U2QX - SODIUM FERRIC GLUCONATE COMPLEX
	Iron is an essential constituent of the body, being necessary for haemoglobin formation and for the oxidative processes of living tissues. More than 80% of the iron present in the body is involved in the support of red blood cell production. Ferrous gluconate is indicated for the prevention and treatment of iron deficiency states.
	Read more about Ferrous gluconate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FERRLECIT Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02243333
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02517463
IL	מִשְׂרַד הַבְּרִיאוּת	6979
US	FDA, National Drug Code	0024-2792, 0024-2794